11:43 AM
 | 
Dec 07, 2017
 |  BC Extra  |  Financial News

Revance raises $150M in follow-on

Revance Therapeutics Inc. (NASDAQ:RVNC) raised $150 million on Thursday through the sale of 4.8 million shares at $31 in a follow-on underwritten by Goldman Sachs, Cowen, Barclays, Cantor Fitzgerald, William Blair...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >